Skip to main content
SpringerLink
Log in

Multiple Endocrine Neoplasia 2 Syndromes

  • Chapter
  • First Online:
Surgical Endocrinopathies

  • 869 Accesses

Abstract

The first case of multiple endocrine neoplasia (MEN) 2 was documented in 1961. Over the past half century, our understanding of MEN 2 has expanded from small kindreds with seemingly inherited constellations of endocrine tumors to three distinct autosomal dominant inherited syndromes: MEN 2A, MEN 2B, and familial medullary thyroid carcinoma (FMTC), which are transmitted by a specific oncogene. Our improved understanding of the rearranged during transfection (RET) proto-oncogene and the clear genotypic–phenotypic relationships it confers to patients with MEN 2 syndrome has significantly changed the diagnosis and clinical management of this disease. As a result, guidelines based on RET genotyping have been developed with an aim to prophylactically treat the most lethal of the MEN 2 endocrine tumors, medullary thyroid cancer (MTC), before it becomes clinically apparent, and to screen for and treat the other two disease manifestations, pheochromocytoma and hyperparathyroidism, in time to reduce morbidity to the patients.

This chapter discusses the historical perspectives on MEN 2, and reviews clinical manifestations of the MEN 2 syndrome subtypes, changes in the diagnoses and management of the involved endocrine tumors (MTC, pheochromocytoma, hyperparathyroidism), RET-MEN 2 genotypic and phenotypic correlations, and current screening and management guidelines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Welbourn, Richard B. The history of endocrine surgery. Praeger: New York; 1990. p. 270–275.

    Google Scholar 

  2. Sipple, John H. The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med. 1961;31(1):163–6.

    Article  Google Scholar 

  3. Marini F, Falchetti A, Del Monte F, et al. Multiple endocrine neoplasia type 2. Orphanet J Rare Dis. 2006;1:45.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19(6):565–612.

    Article  PubMed  Google Scholar 

  5. Moore FD, Scoinski MA, Joste NE. Endocrine tumors and malignancies. In: Skarin A, editor. Atlas of diagnostic oncology. 3rd ed. Philadelphia: Elsevier Science; 2003.

    Google Scholar 

  6. Eng, Charis. RET proto-oncogene in the development of human cancer. J Clin Oncol. 1999;17:380–93.

    CAS  PubMed  Google Scholar 

  7. Gagel RF, Shefelbine S, Hayashi H, Cote G. Multiple endocrine neoplasia type 2. In: Runge MS, Patterson C, editors. Principles of molecular medicine. Ch. 40. NJ: Humana; 2006. p 393–9.

    Google Scholar 

  8. Wells SA Jr, Pacini F, Robinson BG, Santoro M. Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab. 2013;98(8):3149–64.

    Article  CAS  PubMed  Google Scholar 

  9. Raue F, Frank-Raue K. Genotype-phenotype correlation in multiple endocrine neoplasia type 2. Clinics. 2012;67(1):69–75.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Rimoin DL, Schimke, RN. Genetic disorders of the endocrine glands. St. Louis: CV Mosby; 1971. pp. 136–8.

    Google Scholar 

  11. Morrison PJ, Nevin NC. Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). J Med Genetics. 1996;33(9):779–82.

    Article  CAS  Google Scholar 

  12. Mulligan LM1, Marsh DJ, Robinson BG, Schuffenecker I, Zedenius J, Lips CJ, Gagel RF, Takai SI, Noll WW, Fink M, et al. Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Intern Med. 1995;238(4):343–6.

    Article  CAS  PubMed  Google Scholar 

  13. Salehian B, Samoa R. RET gene abnormalities and thyroid disease: who should be screened and when. J Clin Res Pediatr Endocrinol. 2013;5(Suppl 1):70–8.

    Google Scholar 

  14. Rufini V, Treglia G, Castaldi P, Perotti G, Giordano A. Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. Q J Nucl Med Mol Imaging. 2013;57(2):122–33.

    CAS  PubMed  Google Scholar 

  15. Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, Galli G, Fanti S, Giordano A. Comparison of 123I-MIBG SPECT-CT and 18 F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma. Nucl Med Commun. 2011;32(7):575–82.

    Article  PubMed  Google Scholar 

  16. Fonte JS1, Robles JF, Chen CC, Reynolds J, Whatley M, Ling A, Mercado-Asis LB, Adams KT, Martucci V, Fojo T, Pacak K. False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocr Relat Cancer. 2012;19(1):83–93.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Gertner ME, Kebebew E. Multiple endocrine neoplasia type 2. Curr Treat Options Oncol. 2004;5(4):315–25.

    Article  PubMed  Google Scholar 

  18. Asari R, Scheuba C, Kaczirek K, Niederle B. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Arch Surg. 2006;141(12):1199–205; discussion 1205.

    Article  CAS  PubMed  Google Scholar 

  19. Yip L, Lee JE, Shapiro SE, Waguespack SG, Sherman SI, Hoff AO, Gagel RF, Arens JF, Evans DB. Surgical management of hereditary pheochromocytoma. J Am Coll Surg. 2004;198(4):525–34; discussion 534–5.

    Article  PubMed  Google Scholar 

  20. Nagesser SK, Kievit J, Hermans J, Krans HM, van de Velde CJ. The surgical approach to the adrenal gland: a comparison of the retroperitoneal and the transabdominal routes in 326 operations on 284 patients. Jpn J Clin Oncol. 2000;30(2):68–74.

    Article  CAS  PubMed  Google Scholar 

  21. Nigri G, Rosman AS, Petrucciani N, Fancellu A, Pisano M, Zorcolo L, Ramacciato G, Melis M. Meta-analysis of trials comparing laparoscopic transperitoneal and retroperitoneal adrenalectomy. Surgery. 2013;153(1):111–9.

    Article  PubMed  Google Scholar 

  22. Wagner SM, Zhu S, Nicolescu AC, Mulligan LM. Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2. Clinics. 2012;67(1):77–84.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgery Department, New York Presbyterian Hospital, Columbia University Medical Center, 161 Fort Washington Ave, 8th Floor, 10032, New York, NY, USA

    Latha V. Pasupuleti MD & Jennifer H. Kuo MD

Authors
  1. Latha V. Pasupuleti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer H. Kuo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer H. Kuo MD .

Editor information

Editors and Affiliations

  1. Divisions of General Surgery and Surgical Oncology, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

    Janice L. Pasieka

  2. Department of Surgery, Columbia University Medical Center, New York, New York, USA

    James A. Lee

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Pasupuleti, L., Kuo, J. (2015). Multiple Endocrine Neoplasia 2 Syndromes. In: Pasieka, J., Lee, J. (eds) Surgical Endocrinopathies. Springer, Cham. https://doi.org/10.1007/978-3-319-13662-2_61

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13662-2_61

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13661-5

  • Online ISBN: 978-3-319-13662-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation